| Name | Value |
|---|---|
| Revenues | 38.1M |
| Cost of Revenue | 29.1M |
| Gross Profit | 9.0M |
| Operating Expense | 16.0M |
| Operating I/L | -7.6M |
| Other Income/Expense | 0.9M |
| Interest Income | 0.9M |
| Pretax | -6.8M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -6.2M |
IM Cannabis Corp. is a leading player in the medical cannabis industry, specializing in breeding, growing, and supplying medical cannabis products in Israel, Germany, and Canada. The company offers a range of products including cannabis flowers, strain-specific cannabis extracts, dried flower, pre-rolls, and pressed hash under various brands such as IMC, WAGNERS, and Highland Grow. Its customer base includes medical patients and adult-use recreational consumers, positioning the company to generate revenue from both medical and recreational cannabis markets.